Paser
NDC Package 49938-107-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Paser is a medication used in combination with other drugs to treat tuberculosis. Marketed by Jacobus Pharmaceutical Company, Inc., this product is identified by NDC 49938-107 and is authorized under FDA application ANDA074346.

Identification & Billing

NDC Package Code
49938-107-04
Package Description
30 GRANULE, DELAYED RELEASE in 1 CARTON
Product Code
49938-107
11-Digit Billing Format
49938010704
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Paser
Dosage Form
-
Usage Information
This medication is used in combination with other drugs to treat tuberculosis. The treatment of active tuberculosis infection requires taking several drugs in combination for 6 months or longer. This medication may be used as part of this combined drug treatment. Aminosalicylic acid is known as an antituberculosis antibiotic. It works by stopping or slowing the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Jacobus Pharmaceutical Company, Inc.
FDA Application #
ANDA074346
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-15-1995
End Marketing Date
10-31-2022
Listing Expiration
10-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49938-107-04 identifies a specific commercial package of 30 granule, delayed release in 1 carton of Paser, labeled by Jacobus Pharmaceutical Company, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Jacobus Pharmaceutical Company, Inc. on February 15, 1995. The current certification is valid through October 31, 2022.

What are the primary indications for this medication?

This medication is used in combination with other drugs to treat tuberculosis. The treatment of active tuberculosis infection requires taking several drugs in combination for 6 months or longer. This medication may be used as part of this combined drug treatment. Aminosalicylic acid is known as an antituberculosis antibiotic. It works by stopping or slowing the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Jacobus Pharmaceutical Company, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49938010704. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49938-107-04
11-Digit CMS (5-4-2)
49938-0107-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.